NPPB and hydrops fetalis: In comparison with conventional HF therapy, intermittent LEVO infusions in ambulatory patients with end-stage HF are safe and are associated with a mitigated HF progression, reflected by reduction in BNP and improved LV size and function alongside with an improved functional status, less frequent hospitalization, shorter hospital stay, and reduced cardiovascular mortality.